ANGIOGENESIS: A KEY TARGET IN ONCOLOGY - Barcelona, Spain, 28-29 April 2006
FRIDAY APRIL 28, 2006
Welcome
13:30 Welcome & Introduction - E. van Cutsem, G. Gasparini & M. Aapro
Opening Talk
13:35 - 14:05 What is Angiogenesis in Relation to Cancer - G. Breier
Keynote Address
14:05 - 14:35 Developing Bevacizumab - N. Ferrara
Session I Clinically Relevant Basic Data on Angiogenesis
Chairs: K. Alitalo & L. Ellis
14:40 - 15:10 Understanding the Biology of Angiogenesis Part I - T. Tammela (on behalf of K. Alitalo)
15:10 - 15:40 Understanding the Biology of Angiogenesis, Part II - L. Ellis
15:40 - 16:10 Determining VEGF, VEGFR: What Helps the Clinician in Deciding to Use Anti-Angiogenesis Agents? - W.J.P. Steward
Session II Angiogenesis and the Oncologist
Chair: W.J.P. Steward
16:30 - 17:00 Imaging and Angiogenesis - Are There Clinically Useful Clinical Strategies: The Role of Ultrasound - N. Lassau
17:00 - 17:30 Imaging and Angiogenesis - Are There Clinically Useful Clinical Strategies: The Role of PET, CT and MRI - G. Jayson
Session III Angiogenesis: Clinical Usage
08:00 - 08:30 Clinical Management of Anti-Angiogenesis Agents - H. Pinedo
Session IV Today and Tomorrow, Part I
Chairs: E. van Cutsem & K. Miller
08:30 - 09:30 Anti-Angiogenic Therapy in the Treatment of Colorectal Cancer Current Status and Opportunities:
a State-of-the-art Lecture, followed by a Lecture on Anti-Angiogenic Drugs and Their Results - E. van Cutsem & D. Haller
09:30 - 10:30 Anti-Angiogenic Therapy in the Treatment of Breast Cancer Current Status and Opportunities:
a State-of-the-art Lecture - N. Harbeck, followed by a
Lecture on Anti-Angiogenic Drugs and Their Results - J. Bergh & K. Miller
Session V Today and Tomorrow, Part II
Chairs: G. Scagliotti & A. Awada
11:00 - 12:00 Anti-Angiogenic Therapy in the Treatment of Lung Cancer Current Status and Opportunities:
a State-of-the-art Lecture, Followed by a Lecture on Anti-Angiogenic Drugs and Their Results - G. Scagliotti & G. Gasparini
12:00 - 12:20 Anti-Angiogenic Drugs - Different Types, Different Targets: Really Different? - J.P. Armand
12:20 - 12:40 Anti-Angiogenesis Drugs and Prostate: Really Promising? - J. Bellmunt
12:40 - 13:00 Gastric Cancer: How to Position Anti-Angiogenic Drugs - J. Tabernero
13:00 - 13:20 Positioning Anti-angiogenesis Drugs and Other Agents in Renal Cell Cancer Treatment - A. Awada
